Importance of Sleep Deprivation in Differential Diagnosis of Primary Hypersomnia (Actisom dépistage)

Importance of Sleep Deprivation in Differential Diagnosis of Primary Hypersomnia in Reference Centers Rare Hypersomnia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03459300

Acronym

Actisom

Enrollment

100

Registered

2018-03-08

Start date

2018-02-01

Completion date

2020-01-17

Last updated

2021-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypersomnia

Keywords

actimetry

Brief summary

7 to 14 days actimetry recording in order to exclude sleep deprivation just before hospitalisation for differential diagnosis of hypersomnia

Detailed description

This is an observational study Urine drug screening will also be performe The suty includes four centers in France The study duration is of one year

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Men or women aged \> 18 years * Patient with a sleepiness evoking a primary hypersomnia * Epworth sleepiness scale \> 10 * Information note signed

Exclusion criteria

* Patient with type 1 or 2 narcolepsy and/or known hypersomnia * Frank cataplexy * Not stable metabolic, neurological or psychiatric disease * Patient treated by a medicine acting on the central nervous system * Patient having a shift work or having made a transmeridian flight of more than 3 hours lag in the previous month the research * Non affiliation to social security * Pregnancy * Patient under guardianship or curatorship

Design outcomes

Primary

Measure	Time frame	Description
mean total sleep time	7-14 days before hospitalisation	mean total sleep time as measured by actimetry durind the 7 - 14 days before hospitalisation

Countries

France

Outcome results